{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:45:53Z","timestamp":1767797153142,"version":"3.49.0"},"reference-count":32,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Health Research, Ministry of Health and Family Welfare Government of India","award":["R.11014\/42\/2023-GIA\/HR (ID 2022-2197)"],"award-info":[{"award-number":["R.11014\/42\/2023-GIA\/HR (ID 2022-2197)"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) and gestational diabetes mellitus (GDM) are prevalent metabolic disorders in pregnancy, posing significant risks to maternal and fetal health. This study evaluates the effectiveness of metformin, in combination with lifestyle modifications, compared with lifestyle modifications alone, in reducing the incidence of diabetes, pro-inflammatory liver markers, adverse maternal and neonatal outcomes and total gestational weight gain in pregnant women diagnosed with MASLD in the first trimester.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This parallel-arm, randomised controlled trial will recruit pregnant women (\u226414 weeks of gestation) with confirmed MASLD from antenatal clinics of tertiary care public hospitals in Puducherry, India. Participants will be consecutively enrolled until a sample size of 296 is reached. Block randomisation will ensure balanced group allocation, with allocation concealment maintained using sequentially numbered opaque sealed envelopes. The intervention group will receive oral metformin (500\u2009mg two times per day) alongside structured lifestyle modification counselling, while the control group will receive lifestyle modification counselling alone. Primary outcomes include GDM incidence, changes in pro-inflammatory markers, MASLD grading (assessed via liver function tests and ultrasound) and adverse maternal outcomes such as hypertensive disorders, polyhydramnios, genitourinary infections, caesarean delivery and postpartum haemorrhage. Neonatal outcomes assessed include macrosomia, stillbirth, intrauterine death, birth injury, shoulder dystocia, respiratory distress and neonatal hypoglycaemia. The secondary outcome is total gestational weight gain. Participants will be followed at 24\u201328 weeks, 34\u201336 weeks and post partum (within 6\u2009weeks of delivery). Data collection will be conducted using a pretested structured questionnaire, with data entry and management performed using REDCap software. Statistical analysis will be conducted using STATA V.4, applying both intention-to-treat and per-protocol analyses. Effect sizes will be reported as proportions and relative risks with 95% CIs, ensuring robust statistical inference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides a rigorous framework to assess metformin\u2019s role in managing MASLD and preventing GDM, thereby promoting favourable maternal and neonatal outcomes. Findings will contribute to improved clinical management, public health strategies and policy recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study was approved by the JIPMER Institutional Ethics Committee (JIP\/AEC\/2023\/01\/011), and the findings will be disseminated through peer-reviewed journals and academic conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CTRI\/2023\/12\/060930.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093417","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:10:30Z","timestamp":1767111030000},"page":"e093417","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Is metformin therapy in conjunction with lifestyle modifications more effective than lifestyle modifications alone in lowering the risk of gestational diabetes mellitus in pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD)? A protocol for parallel-arm superiority randomised controlled trial in tertiary care centres, Puducherry, South India"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7225-7978","authenticated-orcid":false,"given":"Venkatachalam","family":"Jayaseelan","sequence":"first","affiliation":[{"name":"Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Subbaiah","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, JIPMER, Pondicherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalaiselvy","family":"Arikrishnan","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkumar","family":"Govindarajalu","sequence":"additional","affiliation":[{"name":"Department of Radiology, JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabita","family":"Pulavarthi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Indira Gandhi Medical College and Research Institute, Pondicherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Nanda","sequence":"additional","affiliation":[{"name":"JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadeeja","family":"Nasreen Vadakkepeediyakkal","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pazhanivel","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Medical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"Murugesan Sivagurunathan","sequence":"additional","affiliation":[{"name":"Department of Radiology, IGMC and RI, Pondicherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Kais","family":"Musthafa","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahadevan","family":"Duraiswamy","sequence":"additional","affiliation":[{"name":"JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susmitha","family":"Pulikkot Suragi","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Project Technical Support III, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2026010703490485000_15.12.e093417.1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.14218\/JCTH.2022.00052","article-title":"Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update","volume":"10","author":"Fouda","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"2026010703490485000_15.12.e093417.2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12912"},{"key":"2026010703490485000_15.12.e093417.3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes","volume":"73","author":"Sarkar","year":"2020","journal-title":"J Hepatol"},{"key":"2026010703490485000_15.12.e093417.4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2393-12-23","article-title":"Gestational diabetes and pregnancy outcomes--a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria","volume":"12","author":"Wendland","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026010703490485000_15.12.e093417.5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jgh.12204","article-title":"Non\u2010alcoholic fatty liver disease in diabetics \u2013 prevalence and predictive factors in a multiracial hospital clinic population in m alaysia","volume":"28","author":"Chan","year":"2013","journal-title":"J of Gastro and Hepatol"},{"key":"2026010703490485000_15.12.e093417.6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/ajo.13513","article-title":"Metformin: A promising option for the management of gestational diabetes mellitus - Exploring the benefits, challenges and clinical needs in the current management of gestational diabetes mellitus","volume":"62","author":"Bastian","year":"2022","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2026010703490485000_15.12.e093417.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03869.x"},{"key":"2026010703490485000_15.12.e093417.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02025.x"},{"key":"2026010703490485000_15.12.e093417.9","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1007\/s11033-012-1484-4","article-title":"Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome","volume":"39","author":"Zhou","year":"2012","journal-title":"Mol Biol Rep"},{"key":"2026010703490485000_15.12.e093417.10","doi-asserted-by":"crossref","first-page":"104799","DOI":"10.1016\/j.phrs.2020.104799","article-title":"The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and\/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Jalali","year":"2020","journal-title":"Pharmacol Res"},{"key":"2026010703490485000_15.12.e093417.11","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2174\/1381612827666210315144821","article-title":"The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis","volume":"27","author":"Hu","year":"2021","journal-title":"Curr Pharm Des"},{"key":"2026010703490485000_15.12.e093417.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000759","article-title":"Antidiabetic medication use during pregnancy: an international utilization study","volume":"7","author":"Cesta","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026010703490485000_15.12.e093417.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88650-5","article-title":"Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis","volume":"11","author":"Tarry-Adkins","year":"2021","journal-title":"Sci Rep"},{"key":"2026010703490485000_15.12.e093417.14","doi-asserted-by":"crossref","unstructured":"Salpeter SR , Greyber E , Pasternak GA , et al . Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010.:CD002967. doi:10.1002\/14651858.CD002967.pub3","DOI":"10.1002\/14651858.CD002967.pub3"},{"key":"2026010703490485000_15.12.e093417.15","doi-asserted-by":"crossref","first-page":"102264","DOI":"10.1016\/j.clinre.2023.102264","article-title":"Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease","volume":"48","author":"Xie","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026010703490485000_15.12.e093417.16","unstructured":"Statistics Times . Puducherry population 2024, Available: https:\/\/statisticstimes.com\/demographics\/india\/puducherry-population.php#google_vignette"},{"key":"2026010703490485000_15.12.e093417.17","unstructured":"India - SAMPLE REGISTRATION SYSTEM (SRS)-BULLETIN 2019 VOLUME 54-I, Available: https:\/\/censusindia.gov.in\/nada\/index.php\/catalog\/42686"},{"key":"2026010703490485000_15.12.e093417.18","unstructured":"Health and Family Welfare Services | Official Website of Government of Puducherry, India, Available: https:\/\/py.gov.in\/health-and-family-welfare-services"},{"key":"2026010703490485000_15.12.e093417.19","doi-asserted-by":"crossref","DOI":"10.1186\/s40842-016-0028-6","article-title":"Prevalence of Gestational Diabetes Mellitus in urban and rural Tamil Nadu using IADPSG and WHO 1999 criteria (WINGS 6)","volume":"2","author":"Bhavadharini","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"key":"2026010703490485000_15.12.e093417.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00876.x"},{"key":"2026010703490485000_15.12.e093417.21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch Med Res"},{"key":"2026010703490485000_15.12.e093417.22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","article-title":"Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus","volume":"62","author":"Lee","year":"2019","journal-title":"Diabetologia"},{"key":"2026010703490485000_15.12.e093417.23","unstructured":"ICMR-NATIONAL INSTITUTE OF NUTRITION, Available: https:\/\/www.nin.res.in\/downloads\/My_Plate_for_the_day_J24.pdf"},{"key":"2026010703490485000_15.12.e093417.24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijam.ijam_10_22","article-title":"Diet adherence and factors associated with nonadherence among Type 2 diabetics at an urban health center in Tamil Nadu, India","volume":"9","author":"Selvam","year":"2023","journal-title":"Int J Acad Med"},{"key":"2026010703490485000_15.12.e093417.25","unstructured":"Global Physical Activity Questionnaire (GPAQ) Analysis Guide, Available: http:\/\/www.who.int\/chp\/steps\/GPAQ\/en\/index.html"},{"key":"2026010703490485000_15.12.e093417.26","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.3390\/nu7075231","article-title":"The Reliability and Validity of the Perceived Dietary Adherence Questionnaire for People with Type 2 Diabetes","volume":"7","author":"Asaad","year":"2015","journal-title":"Nutrients"},{"key":"2026010703490485000_15.12.e093417.27","doi-asserted-by":"publisher","DOI":"10.1097\/NT.0000000000000092"},{"key":"2026010703490485000_15.12.e093417.28","unstructured":"Chronic Liver Disease - PubMed, Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/32119484\/"},{"key":"2026010703490485000_15.12.e093417.29","unstructured":"Akanmode AM , Mahdy H . Macrosomia, 2023. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557577\/"},{"key":"2026010703490485000_15.12.e093417.30","article-title":"Molecular Mechanisms of Maternal Diabetes Effects on Fetal and Neonatal Surfactant","volume":"8","author":"Yildiz Atar","year":"2021","journal-title":"Children (Basel)"},{"key":"2026010703490485000_15.12.e093417.31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3803\/EnM.2024.2264","article-title":"Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications","volume":"40","author":"Lee","year":"2025","journal-title":"Endocrinol Metab"},{"key":"2026010703490485000_15.12.e093417.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2004.09.002"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:53:20Z","timestamp":1767786800000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2024-093417"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093417","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}